In late June, Gilead Sciences (GILD) stock surged following positive results of a late-stage trial for its latest HIV drug. The big market buzz was that Gilead was on the verge of something huge, and investors were not about to wait around for proof. They dove in early, seeing the…
In this edition of StockCharts TV‘s The Final Bar, Dave previews earnings releases from TSLA and GOOGL, breaks down key levels…
In this exclusive StockCharts TV video, Joe explains the 1-2-3 reversal pattern, its criteria, and what it will take…
In this edition of StockCharts TV‘s The Final Bar, Dave previews earnings releases from TSLA and GOOGL, breaks down key levels…
Almost everyone felt the ground shake on July 19 when security vendor CrowdStrike (CRWD) initiated a faulty software update…
In this video from StockCharts TV, Julius takes a look at the markets through the lens of the “market…
Tops and bottoms are so much fun to predict, but key signals are not always accurate. That’s where a…
In this edition of StockCharts TV‘s The Final Bar, Dave breaks down today’s upside recovery day for stocks, then shares the…
Friday was a bad day for CrowdStrike Holdings (CRWD) as a bug was pushed out that disrupted Windows machines…